These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37449818)

  • 1. Synthesis of Bleomycin-Inspired RNA Ligands Targeting the Biogenesis of Oncogenic miRNAs.
    Maucort C; Bonnet M; Ortuno JC; Tucker G; Quissac E; Verreault M; Azoulay S; Di Giorgio C; Di Giorgio A; Duca M
    J Med Chem; 2023 Aug; 66(15):10639-10657. PubMed ID: 37449818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
    Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
    ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule approaches toward the targeting of oncogenic miRNAs: roadmap for the discovery of RNA modulators.
    Di Giorgio A; Tran TP; Duca M
    Future Med Chem; 2016 May; 8(7):803-16. PubMed ID: 27149207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates.
    Vo DD; Tran TP; Staedel C; Benhida R; Darfeuille F; Di Giorgio A; Duca M
    Chemistry; 2016 Apr; 22(15):5350-62. PubMed ID: 26928593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncoding RNAs in breast cancer.
    Lo PK; Wolfson B; Zhou X; Duru N; Gernapudi R; Zhou Q
    Brief Funct Genomics; 2016 May; 15(3):200-21. PubMed ID: 26685283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
    Tran TP; Vo DD; Di Giorgio A; Duca M
    Bioorg Med Chem; 2015 Sep; 23(17):5334-44. PubMed ID: 26264847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
    Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
    Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers.
    Barwal TS; Sharma U; Bazala S; Singh I; Jain M; Prakash H; Shekhar S; Sandberg EN; Bishayee A; Jain A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Degradation of the Oncogenic MicroRNA 17-92 Cluster by Structure-Targeting Ligands.
    Liu X; Haniff HS; Childs-Disney JL; Shuster A; Aikawa H; Adibekian A; Disney MD
    J Am Chem Soc; 2020 Apr; 142(15):6970-6982. PubMed ID: 32233464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of Multimodal Small Molecules Targeting miRNAs Biogenesis: Synthesis and In Vitro Evaluation.
    Vo DD; Duca M
    Methods Mol Biol; 2017; 1517():137-154. PubMed ID: 27924480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncoding RNAs: New Players in Cancers.
    Chen X; Fan S; Song E
    Adv Exp Med Biol; 2016; 927():1-47. PubMed ID: 27376730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
    Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
    Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs: molecular features and role in cancer.
    Lages E; Ipas H; Guttin A; Nesr H; Berger F; Issartel JP
    Front Biosci (Landmark Ed); 2012 Jun; 17(7):2508-40. PubMed ID: 22652795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs: non coding pleiotropic factors in development, cancer prevention and treatment.
    Fazi F; Blandino G
    Microrna; 2013; 2(2):81. PubMed ID: 25070777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment.
    Spizzo R; Rushworth D; Guerrero M; Calin GA
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S313-8. PubMed ID: 19778859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncoding RNAs in cancer and cancer stem cells.
    Huang T; Alvarez A; Hu B; Cheng SY
    Chin J Cancer; 2013 Nov; 32(11):582-93. PubMed ID: 24206916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncoding RNAs and pancreatic cancer.
    Peng JF; Zhuang YY; Huang FT; Zhang SN
    World J Gastroenterol; 2016 Jan; 22(2):801-14. PubMed ID: 26811626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer.
    Maruyama R; Suzuki H; Yamamoto E; Imai K; Shinomura Y
    Tumour Biol; 2012 Apr; 33(2):277-85. PubMed ID: 22219034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential applications of polyphenols on main ncRNAs regulations as novel therapeutic strategy for cancer.
    Yi J; Li S; Wang C; Cao N; Qu H; Cheng C; Wang Z; Wang L; Zhou L
    Biomed Pharmacother; 2019 May; 113():108703. PubMed ID: 30870719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
    Arjumand W; Asiaf A; Ahmad ST
    Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.